Skip to main content
. 2014 Sep 25;12:298. doi: 10.1186/1477-7819-12-298

Figure 3.

Figure 3

Overall survival of patients with parietal and/or peritoneal localization (PPL) recurrences of hepatocellular carcinoma (Group 1), patients with non-PPL extrahepatic metastases (Group 2) and patients with intrahepatic-only recurrence (Group 3) after treatment of primary hepatocarcinoma.